Gastric Pacemaker Implantation for Gastroparesis (HUD)
Primary Purpose
Gastroparesis
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Enterra Gastric Pacemaker
Sponsored by
About this trial
This is an interventional treatment trial for Gastroparesis focused on measuring Gastroparesis, Gastric electrical stimulator
Eligibility Criteria
Inclusion Criteria:
- Used only if patients have tried and failed conventional treatment ( drug therapy and dietary modification)due to intractable nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Treatement
Arm Description
All subjects that meet the requirement for gastric stimulator placement
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00568373
Brief Title
Gastric Pacemaker Implantation for Gastroparesis
Acronym
HUD
Official Title
Gastric Electric Stimulation-Enterra Therapy for the Treatment of Chronic Intractable (Drug Refractory) Nausea and Vomiting Secondary to Gastroparesis of Diabetic or Idiopathic Etiology
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Withdrawn
Why Stopped
this is not a clinical trial and does not require registration
Study Start Date
June 2007 (Anticipated)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Indiana University
4. Oversight
5. Study Description
Brief Summary
Gastric pacemakers and/or temporary gastric stimulators will be implanted in eligible patients.
Detailed Description
Due to HUD status, this protocol is for implant only. This is NOT a clinical trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastroparesis
Keywords
Gastroparesis, Gastric electrical stimulator
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All patients who have severe symptoms and have been identified by the PI and Sub I to qualify for the treatment will be under one single group
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Treatement
Arm Type
Experimental
Arm Description
All subjects that meet the requirement for gastric stimulator placement
Intervention Type
Device
Intervention Name(s)
Enterra Gastric Pacemaker
Intervention Description
Gastric Pacemaker
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Used only if patients have tried and failed conventional treatment ( drug therapy and dietary modification)due to intractable nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Gastric Pacemaker Implantation for Gastroparesis
We'll reach out to this number within 24 hrs